<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Reported-in-Senate" dms-id="A1" public-private="public">
	<form>
		<distribution-code display="yes">II</distribution-code>
		<calendar>Calendar No. 121</calendar>
		<congress>112th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 839</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20110414">April 14, 2011</action-date>
			<action-desc><sponsor name-id="S311">Ms. Klobuchar</sponsor> (for
			 herself, <cosponsor name-id="S153">Mr. Grassley</cosponsor>, and
			 <cosponsor name-id="S341">Mr. Blumenthal</cosponsor>) introduced the following
			 bill; which was read twice and referred to the
			 <committee-name added-display-style="italic" committee-id="SSJU00" deleted-display-style="strikethrough">Committee on the
			 Judiciary</committee-name></action-desc>
		</action>
		<action stage="Reported-in-Senate">
			<action-date date="20110728">July 28, 2011</action-date>
			<action-desc>Reported by <sponsor name-id="S057">Mr. Leahy</sponsor>,
			 without amendment</action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To ban the sale of certain synthetic
		  drugs.</official-title>
	</form>
	<legis-body>
		<section id="idD7513541577F4BADA70BED9C13E0C908" section-type="section-one"><enum>1.</enum><header>Short title</header>
			<subsection id="id3C490E94604A458BB1853F053C047689"><enum>(a)</enum><header>Short
			 title</header><text>This Act may be cited as the <quote><short-title>Combating Designer Drugs Act of
			 2011</short-title></quote>.</text>
			</subsection></section><section id="id0DD7C5106B884549B3DFEE71B2DC493A"><enum>2.</enum><header>Controlled
			 Substances Act</header><text display-inline="no-display-inline">Schedule I of
			 section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended
			 in subsection (c) by adding at the end the following:</text>
			<quoted-block display-inline="no-display-inline" id="idCA2721A63AD34D25B4F0DEFAFA68C027" style="OLC">
				<paragraph id="idFF0B3DA261B14A36BFA96982EC5AEFDD"><enum>(18)</enum><text display-inline="yes-display-inline">2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine
				(2C-E).</text>
				</paragraph><paragraph id="ID9a5d770098d94fc0b7c48b01b8b40296"><enum>(19)</enum><text>2-(2,5-Dimethoxy-4-methylphenyl)ethanamine
				(2C-D).</text>
				</paragraph><paragraph id="IDa9669f3ceb1f40af85a079e8f076be85"><enum>(20)</enum><text>2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine
				(2C-C).</text>
				</paragraph><paragraph id="ID6b799de4ad14490ab516e2ab2c462361"><enum>(21)</enum><text>2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine
				(2C-I).</text>
				</paragraph><paragraph id="IDeb37b6824edb4c45b8c71758e94912aa"><enum>(22)</enum><text>2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine
				(2C-T-2).</text>
				</paragraph><paragraph id="ID86fce8150919409db3757ddc83e074b8"><enum>(23)</enum><text>2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine
				(2C-T-4).</text>
				</paragraph><paragraph id="ID8e2a3fd9d92a4adbb934238f54af1bb4"><enum>(24)</enum><text>2-(2,5-Dimethoxyphenyl)ethanamine
				(2C-H).</text>
				</paragraph><paragraph id="IDa9866ace2beb48f184ea7d98a17e8071"><enum>(25)</enum><text>2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine
				(2C-N).</text>
				</paragraph><paragraph id="ID96d12ba35e16438986b7d14e75a82310"><enum>(26)</enum><text>2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine
				(2C-P).</text>
				</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
		</section></legis-body>
	<endorsement>
		<action-date>July 28, 2011</action-date>
		<action-desc>Reported without amendment</action-desc>
	</endorsement>
</bill>
